07.01.03
Nutri Pharma, Amersham, Bucks, U.K. has released the results of a clinical trial demonstrating that its new isolated soy protein (ISP) is successful at lowering serum cholesterol values. In a placebo-controlled, double-blind study of 120 hypercholesterolemic individuals, Nutri Pharma’s new ISP decreased serum cholesterol and LDL cholesterol significantly more than the control ISP. The serum LDL-cholesterol reduction with the Nutri Pharma ISP was 92% greater than with the control ISP. Nutri Parma's new ISP also reported as being more than 95% soluble.